Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 215 publications

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 06, 2025

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 31, 2025

Critical demyelinating lesions in progressive multiple sclerosis: a prospective observational study.

Critical demyelinating lesions in progressive multiple sclerosis: a prospective observational study.

Journal: Journal of neurology
Published: May 27, 2025

Emerging Role of Targeted Monoclonal Antibodies in Neuromyelitis Optica Spectrum Disorders.

Emerging Role of Targeted Monoclonal Antibodies in Neuromyelitis Optica Spectrum Disorders.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: May 11, 2025

Analysis of infection rates in neuromyelitis optica spectrum disorder: Comparing satralizumab treatment in SAkuraMoon, post-marketing, and US-based health claims data.

Analysis of infection rates in neuromyelitis optica spectrum disorder: Comparing satralizumab treatment in SAkuraMoon, post-marketing, and US-based health claims data.

Journal: Multiple sclerosis and related disorders
Published: December 22, 2024

Utility of spinal cord axial-T2 sequence in a population-based cohort of multiple sclerosis.

Utility of spinal cord axial-T2 sequence in a population-based cohort of multiple sclerosis.

Journal: Journal of neurology
Published: December 17, 2024

Cerebellar Involvement in Attacks of Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder.

Cerebellar Involvement in Attacks of Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: December 11, 2024

McArdle sign and neck flexion-induced change in central motor conduction in multiple sclerosis.

McArdle sign and neck flexion-induced change in central motor conduction in multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: November 06, 2024

Application and interpretation of core elements of the 2015 NMOSD diagnostic criteria in routine clinical practice.

Application and interpretation of core elements of the 2015 NMOSD diagnostic criteria in routine clinical practice.

Journal: Frontiers in immunology
Published: October 22, 2024

Effects of androgen modifying therapies on disease activity in older men with multiple sclerosis.

Effects of androgen modifying therapies on disease activity in older men with multiple sclerosis.

Journal: Journal of neuroimmunology
Published: September 30, 2024

Relapsing tumefactive demyelination: time to recognize a distinct demyelinating condition?

Relapsing tumefactive demyelination: time to recognize a distinct demyelinating condition?

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 09, 2024

At home e-based physical exercise programs in patients with multiple sclerosis: a scoping review.

At home e-based physical exercise programs in patients with multiple sclerosis: a scoping review.

Journal: Frontiers in neurology
Published: June 15, 2024
Showing 1-12 of 215

Last Updated: 10/31/2025